(Q44247511)

English

Meta-analysis of results from eight randomized, placebo-controlled trials on the effect of cilostazol on patients with intermittent claudication

scientific article published in December 2002

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

0 references

Meta-analysis of results from eight randomized, placebo-controlled trials on the effect of cilostazol on patients with intermittent claudication (English)

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Paul D Thompson

1

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Richard Zimet

2

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

William P Forbes

3

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Peter Zhang

4

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

language of work or name

0 references

publication date

1 December 2002

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

American Journal of Cardiology

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

90

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

12

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

1314-1319

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Cilostazol has beneficial effects in treatment of intermittent claudication: results from a multicenter, randomized, prospective, double-blind trial

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902869-2

7 January 2021

A new pharmacological treatment for intermittent claudication: results of a randomized, multicenter trial

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902869-2

7 January 2021

Effect of cilostazol on walking distances in patients with intermittent claudication caused by peripheral vascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902869-2

7 January 2021

Effect of the novel antiplatelet agent cilostazol on plasma lipoproteins in patients with intermittent claudication

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902869-2

7 January 2021

A comparison of cilostazol and pentoxifylline for treating intermittent claudication

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902869-2

7 January 2021

Trans-atlantic conference on clinical trial guidelines in PAOD (Peripheral arterial occlusive disease) clinical trial methodology

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902869-2

7 January 2021

The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902869-2

7 January 2021

Update on Some Epidemiologic Features of Intermittent Claudication: The Framingham Study

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902869-2

7 January 2021

The demographics of claudication and the aging of the American population

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902869-2

7 January 2021

Correlation of hemodynamic and functional variables with the angiographic extent of peripheral arterial occlusive disease

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902869-2

7 January 2021

The effect of withdrawal of drugs treating intermittent claudication

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902869-2

7 January 2021

Claudication distance is poorly estimated and inappropriately measured

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902869-2

7 January 2021

Identifiers

10.1016/S0002-9149(02)02869-2

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44247511&oldid=2108893554"